Cell Therapy Technologies Global Market Opportunities And Strategies To 2032

This report describes and explains the cell therapy technologies market and covers 2017-2022, termed the historic period, and 2022-2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.

The global cell therapy technologies market reached a value of nearly $3,557.8 million in 2022, having grown at a compound annual growth rate (CAGR) of 14.2% since 2017. The market is expected to grow from $3,557.8 million in 2022 to $ 7,550.1 million in 2027 at a rate of 16.2%. The market is then expected to grow at a CAGR of 14.3% from 2027 and reach $ 14,703.9 million in 2032.

Growth in the historic period resulted from strong economic growth in emerging markets, increased healthcare expenditure, increased investments by the government in cell-based research, and growing demand for personalized medicine. Factors that negatively affected growth in the historic period were high costs associated with cell therapy, low healthcare access, and challenges due to regulatory changes.

Going forward, rising aging population, increasing prevalence of cancer, increasing research and development spending in pharmaceutical sector, and advancements in cell therapies will drive the growth. Factors that could hinder the growth of the cell therapy technologies market in the future include shortage of skilled professionals, the Russia-Ukraine war, and stringent regulations.

The cell therapy technologies market is segmented by product into consumables, equipment, and systems & software. The consumables market was the largest segment of the cell therapy technologies market segmented by product, accounting for 52.8% of the total in 2022. Going forward, the equipment segment is expected to be the fastest growing segment in the cell therapy technologies market segmented by product, at a CAGR of 17.2% during 2022-2027.

The cell therapy technologies market is segmented by cell type into T-cells, stem cells, and other cells. The T-cells market was the largest segment of the cell therapy technologies market segmented by cell type, accounting for 75.9% of the total in 2022. Going forward, the other cells segment is expected to be the fastest growing segment in the cell therapy technologies market segmented by cell type, at a CAGR of 17.4% during 2022-2027.

The cell therapy technologies market is segmented by end user into life science companies, research institutes and cell banks. The life science companies market was the largest segment of the cell therapy technologies market segmented by end user, accounting for 77.4% of the total in 2022. Going forward, the life science companies segment is expected to be the fastest growing segment in the cell therapy technologies market segmented by end user, at a CAGR of 16.9% during 2022-2027.

The cell therapy technologies market is segmented by process into cell processing, cell preservation, distribution and handling, and process monitoring and quality control. The cell processing market was the largest segment of the cell therapy technologies market segmented by process, accounting for 45.0% of the total in 2022. Going forward, the cell processing segment is expected to be the fastest growing segment in the cell therapy technologies market segmented by process, at a CAGR of 16.9% during 2022-2027.

North America was the largest region in the cell therapy technologies market, accounting for 67.1% of the total in 2022. It was followed by Western Europe, and then the other regions. Going forward, the fastest-growing regions in the cell therapy technologies market will be Western Europe and Asia Pacific where growth will be at CAGRs of 27.5% and 5.4% respectively.

The global cell therapy technologies market is concentrated, with a few large players. The top ten competitors in the market made up to 84.55% of the total market in 2021. This can be due to the existence of number of local players in the market serving customers in particular geographies. Lonza Group AG was the largest competitor with 16.90% share of the market, followed by Thermo Fisher Scientific, Inc. with 16.09%, Merck KGaA with 10.93%, Terumo Corporation with 9.37%, Danaher Corporation with 7.70%, Fresenius Medical Care AG & Co. KGaA with 6.42%, Fujifilm Holdings Corporation with 5.61%, Sartorius AG with 4.68%, Becton, Dickinson and Company with 4.48% and Avantor, Inc. with 3.38%.

The top opportunities in the cell therapy technologies market segmented by product will arise in the consumables segment, which will gain $3,872.7 million of global annual sales by 2027. The top opportunities in the cell therapy technologies market segmented by cell type will arise in the T-cells segment, which will gain $5,714.4 million of global annual sales by 2027. The top opportunities in the cell therapy technologies market segmented by end user will arise in the life sciences companies segment, which will gain $6,002.0 million of global annual sales by 2027. The top opportunities in the cell therapy technologies market segmented by process will arise in the cell processing segment, which will gain $3,497.7 million of global annual sales by 2027. The cell therapy technologies market size will gain the most in the USA at $739.6 million.

Market-trend-based strategies for the cell therapy technologies market include focus on developing innovative products, using advanced technologies, development of innovative cell therapies, investing in manufacturing facility, and partnerships and collaborations.

Player-adopted strategies in the cell therapy technologies market include securing regulatory approvals, launch of new solutions, strategic acquisitions, and strategic collaboration and partnerships.

To take advantage of the opportunities, the publisher recommends the cell therapy technologies companies to focus on technological advancements, focus on product innovations, focus on development of innovative cell therapies, focus on fast-growing products, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, target fast-growing end-users, continue to target fast-growing processes, and target the elderly population.